Last reviewed · How we verify
low sodium dialysis
At a glance
| Generic name | low sodium dialysis |
|---|---|
| Sponsor | Yuzuncu Yil University |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD) (PHASE4)
- Effect of Low Versus High Dialysate Sodium Concentration During Hemodialysis on Dialysis Recovery Time (NA)
- IHD Versus CRRT for Severe Acute Kidney Injury in Critically Ill Patients (NA)
- Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease (NA)
- Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension (NA)
- Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula (NA)
- The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease
- The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |